Lip oils — including those marketed with peptide-based anti-aging, plumping, or firming claims — are regulated as cosmetics in the USA, not drugs. Cosmetics do not require pre-market FDA approval. However, since the Modernization of Cosmetics Regulation Act (MoCRA) of December 2022, there are mandatory compliance steps that every brand and manufacturer must complete, and getting them wrong exposes your brand to an FDA warning letter or enforcement action.
Facility registration is now mandatory. Both the manufacturing facility and any co-manufacturing facility that fills your product must be registered with the FDA. Registrations were due by December 29, 2023 for large facilities, and December 29, 2024 for smaller facilities. Confirm your manufacturer is registered — this is table stakes, not a bonus.
Product listing is also mandatory under MoCRA. For each cosmetic product you market in the USA, you or your manufacturer must submit a product listing to the FDA that includes the product name, responsible party contact information, and the full ingredient list. This is an annual obligation. Many small brands are unaware of this requirement because it was not required under the old FPLA framework.
Ingredient safety is the brand owner's responsibility. Unlike drugs, no pre-approval process exists, but you are legally responsible for ensuring every ingredient in your formula — including every peptide — is safe as used. This means having a safety assessment on file. If you plan to sell in the EU simultaneously, you will need a formal Cosmetic Product Safety Report (CPSR) authored by a qualified toxicologist; some USA brands commission this report anyway because it covers both markets.
Label compliance is required under 21 CFR Part 701. Your label must include: product identity statement, net contents, responsible party name and address, and a full INCI ingredient list in descending order of predominance. Peptides must be listed under their INCI names, not trade names — for example, acetyl hexapeptide-3, not "Argireline."
Claims matter. If you write "reduces wrinkles by 40%" or "stimulates collagen production," the FDA may reclassify your product as a drug claim, triggering drug registration requirements. Stick to structure-function cosmetic language: "visibly smooths the appearance of fine lines," "helps lips look fuller," "provides a plumping effect." Your manufacturer or a cosmetic regulatory consultant can review your claims before launch.
Prop 65 (California): If you sell to California consumers, your formula must be screened against the Prop 65 list of chemicals known to cause cancer or reproductive harm. Most standard lip oil ingredients pass, but confirm with your supplier.
None of this requires FDA approval before you sell — but non-compliance is a real risk. Choose a manufacturer that is already MoCRA-registered and can provide your product listing documentation as part of their service. This is a differentiating criterion you can evaluate on AJ Cosmo Labs when comparing manufacturers.
Ingredients in this answer: Argireline
Read the full guide on Private Label Peptide Lip Oil Manufacturer USA Low MOQ →